McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Dominic J. Caruso DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Lynne M. Doughtie DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: W. Roy Dunbar DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Deborah Dunsire, M.D. DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Julie L. Gerberding, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: James H. Hinton DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Donald R. Knauss DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Bradley E. Lerman DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Maria N. Martinez DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Kevin M. Ozan DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Brian S. Tyler DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Election of Twelve Directors for a One-Year Term: Kathleen Wilson-Thompson DIRECTOR ELECTIONS ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2026 AUDIT-RELATED ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 McKesson Corporation 58155Q103 US58155Q1031 07/30/2025 Advisory Vote to Approve the Company's Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 79900.000000 0 FOR 79900.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 11/03/2025 Adopt New Articles of Association CORPORATE GOVERNANCE ISSUER 439010.000000 0 FOR 439010.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Robert W. Azelby DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Michelle M. Brennan DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Sheri H. Edison DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: David C. Evans DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Patricia A. Hemingway Hall DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Jason M. Hollar DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Akhil Johri DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Gregory B. Kenny DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Nancy Killefer DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Christine A. Mundkur DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Robert W. Musslewhite DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 Election of Directors: Sudhakar Ramakrishna DIRECTOR ELECTIONS ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Cardinal Health, Inc. 14149Y108 US14149Y1082 11/05/2025 To ratify the appointment of Ernst & Young LLP as our independent auditor for the fiscal year ending June 30, 2026 AUDIT-RELATED ISSUER 136300.000000 0 FOR 136300.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 11/14/2025 Elect Lars Rebien Sorensen (Chair) as New Director DIRECTOR ELECTIONS COMPENSATION SECURITY HOLDER 633259.000000 0 ABSTAIN 633259.000000 NONE S000005666 Novo Nordisk A/S K72807140 DK0062498333 11/14/2025 Elect Cees de Jong (Vice Chair) as New Director DIRECTOR ELECTIONS COMPENSATION SECURITY HOLDER 633259.000000 0 ABSTAIN 633259.000000 NONE S000005666 Novo Nordisk A/S K72807140 DK0062498333 11/14/2025 Elect Britt Meelby Jensen as New Director DIRECTOR ELECTIONS COMPENSATION SECURITY HOLDER 633259.000000 0 ABSTAIN 633259.000000 NONE S000005666 Novo Nordisk A/S K72807140 DK0062498333 11/14/2025 Elect Mikael Dolsten as New Director DIRECTOR ELECTIONS COMPENSATION SECURITY HOLDER 633259.000000 0 ABSTAIN 633259.000000 NONE S000005666 Novo Nordisk A/S K72807140 DK0062498333 11/14/2025 Elect Stephan Engels as New Director DIRECTOR ELECTIONS COMPENSATION SECURITY HOLDER 633259.000000 0 ABSTAIN 633259.000000 NONE S000005666 argenx SE N0610Q109 NL0010832176 11/18/2025 Approve Remuneration Policy COMPENSATION ISSUER 26167.000000 0 FOR 26167.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: William M. Brown DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Carrie L. Byington DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: R. Andrew Eckert DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Claire M. Fraser DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Gregory J. Hayes DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Jeffrey W. Henderson DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Robert L. Huffines DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Christopher Jones DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Thomas E. Polen DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Bertram L. Scott DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Joanne Waldstreicher DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Election of Directors: Jacqueline Wright DIRECTOR ELECTIONS ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Ratification of the selection of the independent registered public accounting firm AUDIT-RELATED ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Becton, Dickinson and Company 075887109 US0758871091 01/27/2026 Approval of an amendment to the 2004 Employee and Director Equity-Based Compensation Plan COMPENSATION ISSUER 88700.000000 0 FOR 88700.000000 FOR S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Approve Non-Financial Report CORPORATE GOVERNANCE ENVIRONMENT OR CLIMATE HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Approve Discharge of Board and Senior Management CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Approve Allocation of Income and Dividends of CHF 3.70 per Share CAPITAL STRUCTURE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Approve CHF 38 Million Reduction in Share Capital via Cancellation of Repurchased Shares CAPITAL STRUCTURE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Approve Remuneration of Directors in the Amount of CHF 8.2 Million COMPENSATION ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Approve Remuneration of Executive Committee in the Amount of CHF 95 Million COMPENSATION ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Approve Remuneration Report COMPENSATION ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Giovanni Caforio as Director and Board Chair DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Nancy Andrews as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Ton Buechner as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Patrice Bula as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Elizabeth Doherty as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Bridgette Heller as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Frans van Houten as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Elizabeth McNally as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Simon Moroney as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect Ana de Pro Gonzalo as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reelect John Young as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Elect Charles Swanton as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reappoint Patrice Bula as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reappoint Bridgette Heller as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reappoint Simon Moroney as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Reappoint John Young as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Appoint Elizabeth McNally as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Ratify KPMG AG as Auditors AUDIT-RELATED ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Designate Peter Zahn as Independent Proxy CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Novartis AG H5820Q150 CH0012005267 03/06/2026 Transact Other Business (Voting) CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Elect Chair of Meeting CORPORATE GOVERNANCE ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Approve Treatment of Net Loss CAPITAL STRUCTURE ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Reelect Albert Cha as Director DIRECTOR ELECTIONS ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Reelect Lars Holtug as Director DIRECTOR ELECTIONS ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Reelect Jan Moller Mikkelsen as Director DIRECTOR ELECTIONS ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Reelect Lisa Jane Morrison as Director DIRECTOR ELECTIONS ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Reelect William Carl Fairey Jr as Director DIRECTOR ELECTIONS ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Reelect Siham Imani as Director DIRECTOR ELECTIONS ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Elect Jean-Jacques Bienaime as New Director DIRECTOR ELECTIONS ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Ratify Deloitte as Auditor AUDIT-RELATED ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Ascendis Pharma A/S K08588103 DK0060615755 03/23/2026 Authorize Share Repurchase Program CAPITAL STRUCTURE ISSUER 107488.000000 6300.000000 FOR 107488.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Approve Allocation of Income, with a Final Dividend of JPY 147 CAPITAL STRUCTURE ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Elect Director Okuda, Osamu DIRECTOR ELECTIONS ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Elect Director Taniguchi, Iwaaki DIRECTOR ELECTIONS ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Elect Director Iikura, Hitoshi DIRECTOR ELECTIONS ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Elect Director Tateishi, Fumio DIRECTOR ELECTIONS ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Elect Director Teramoto, Hideo DIRECTOR ELECTIONS ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Elect Director Mitani, Kinuko DIRECTOR ELECTIONS ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Elect Director Thomas Schinecker DIRECTOR ELECTIONS ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Elect Director Teresa A. Graham DIRECTOR ELECTIONS ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Elect Director Boris L. Zaitra DIRECTOR ELECTIONS ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Chugai Pharmaceutical Co., Ltd. J06930101 JP3519400000 03/26/2026 Approve Trust-Type Equity Compensation Plan COMPENSATION ISSUER 296300.000000 0 FOR 296300.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 610832.000000 0 FOR 610832.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Approve Allocation of Income and Dividends of DKK 7.95 Per Share CAPITAL STRUCTURE ISSUER 610832.000000 0 FOR 610832.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Approve Remuneration Report (Advisory Vote) COMPENSATION ISSUER 610832.000000 0 FOR 610832.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Approve Remuneration of Directors for 2025 COMPENSATION ISSUER 610832.000000 0 FOR 610832.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Approve Remuneration Level of Directors for 2026 COMPENSATION ISSUER 610832.000000 0 FOR 610832.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Reelect Lars Rebien Sorensen (Chair) as Director DIRECTOR ELECTIONS ISSUER 610832.000000 0 ABSTAIN 610832.000000 AGAINST S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Reelect Cees de Jong (Vice Chair) as Director DIRECTOR ELECTIONS ISSUER 610832.000000 0 ABSTAIN 610832.000000 AGAINST S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Reelect Britt Meelby Jensen as Director DIRECTOR ELECTIONS ISSUER 610832.000000 0 ABSTAIN 610832.000000 AGAINST S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Reelect Kasim Kutay as Director DIRECTOR ELECTIONS ISSUER 610832.000000 0 ABSTAIN 610832.000000 AGAINST S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Reelect Stephan Engels as Director DIRECTOR ELECTIONS ISSUER 610832.000000 0 ABSTAIN 610832.000000 AGAINST S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Elect Helena Saxon as New Director DIRECTOR ELECTIONS ISSUER 610832.000000 0 ABSTAIN 610832.000000 AGAINST S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Elect Jan van de Winkel as New Director DIRECTOR ELECTIONS ISSUER 610832.000000 0 ABSTAIN 610832.000000 AGAINST S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Elect Ramona Sequeira as New Director DIRECTOR ELECTIONS ISSUER 610832.000000 0 ABSTAIN 610832.000000 AGAINST S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Ratify Deloitte as Auditors; Ratify Deloitte as Auditors for Sustainability Reporting AUDIT-RELATED ISSUER 610832.000000 0 FOR 610832.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Authorize Share Repurchase Program CAPITAL STRUCTURE ISSUER 610832.000000 0 FOR 610832.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Approve Creation of DKK 44.7 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 44.7 Million Pool of Capital without Preemptive Rights; Maximum Increase in Share Capital under Both Authorizations up to DKK 44.7 Million CAPITAL STRUCTURE ISSUER 610832.000000 0 FOR 610832.000000 FOR S000005666 Novo Nordisk A/S K72807140 DK0062498333 03/26/2026 Change Location of General Meeting to Eastern Denmark CORPORATE GOVERNANCE ISSUER 610832.000000 0 FOR 610832.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Approve Dividends CAPITAL STRUCTURE ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Appoint KPMG LLP as Auditors AUDIT-RELATED ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Authorise Board to Fix Remuneration of Auditors AUDIT-RELATED ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Michel Demare as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Pascal Soriot as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Aradhana Sarin as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Philip Broadley as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Euan Ashley as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Birgit Conix as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Rene Haas as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Karen Knudsen as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Diana Layfield as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Anna Manz as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Sheri McCoy as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Tony Mok as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Re-elect Marcus Wallenberg as Director DIRECTOR ELECTIONS ISSUER 368545.000000 0 AGAINST 368545.000000 AGAINST S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Approve Remuneration Report COMPENSATION ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Amend Performance Share Plan COMPENSATION ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Authorise UK Political Donations and Expenditure OTHER SOCIAL ISSUES ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Authorise Issue of Equity CAPITAL STRUCTURE ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Authorise Issue of Equity without Pre-emptive Rights CAPITAL STRUCTURE ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment CAPITAL STRUCTURE ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Authorise Market Purchase of Ordinary Shares CAPITAL STRUCTURE ISSUER 368545.000000 0 FOR 368545.000000 FOR S000005666 AstraZeneca PLC G0593M107 GB0009895292 04/09/2026 Authorise the Company to Call General Meeting with Two Weeks' Notice CORPORATE GOVERNANCE ISSUER 368545.000000 0 AGAINST 368545.000000 AGAINST S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: John W. Chidsey, III DIRECTOR ELECTIONS ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Wayne J. Riley, M.D. DIRECTOR ELECTIONS ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 45780.000000 0 FOR 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. OTHER SOCIAL ISSUES SECURITY HOLDER 45780.000000 0 AGAINST 45780.000000 FOR S000005666 HCA Healthcare, Inc. 40412C101 US40412C1018 04/23/2026 Stockholder proposal, if properly presented at the meeting, regarding stockholders' right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 45780.000000 0 AGAINST 45780.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: John G. Morikis DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Daniel E. Pinto DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 569943.000000 0 FOR 569943.000000 FOR S000005666 Johnson & Johnson 478160104 US4781601046 04/23/2026 Independent Board Chair CORPORATE GOVERNANCE SECURITY HOLDER 569943.000000 0 AGAINST 569943.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: N. Ahuja DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Incentive Stock Program COMPENSATION ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Abbott Laboratories 002824100 US0028241000 04/24/2026 Approval of the Abbott Laboratories 2026 Employee Stock Purchase Plan for Non-U.S. Employees COMPENSATION ISSUER 135900.000000 0 FOR 135900.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Consolidated Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Allocation of Income and Dividends of EUR 4.12 per Share CAPITAL STRUCTURE ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Reelect Christophe Babule as Director DIRECTOR ELECTIONS ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Reelect Jean-Paul Kress as Director DIRECTOR ELECTIONS ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Elect Belen Garijo as Director DIRECTOR ELECTIONS ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Elect Christel Heydemann as Director DIRECTOR ELECTIONS ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Compensation Report of Corporate Officers COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Compensation of Frederic Oudea, Chairman of the Board COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Compensation of Paul Hudson, CEO COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Remuneration of Directors in the Aggregate Amount of EUR 3,200,000 COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Remuneration Policy of Directors COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Remuneration Policy of Chairman of the Board COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Remuneration Policy of Paul Hudson, CEO Until February 17, 2026 COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Remuneration Policy of Olivier Charmeil, Acting CEO COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Approve Remuneration Policy of Belen Garijo, Future CEO COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Authorize Repurchase of Up to 10 Percent of Issued Share Capital CAPITAL STRUCTURE ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Amend Article 16 of Bylaws Re: Age Limit of CEO CORPORATE GOVERNANCE ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Authorize Capital Issuances for Use in Employee Stock Purchase Plans COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees and Corporate Officers of International Subsidiaries COMPENSATION ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Sanofi F5548N101 FR0000120578 04/29/2026 Authorize Filing of Required Documents/Other Formalities CORPORATE GOVERNANCE ISSUER 540411.000000 0 FOR 540411.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: David C. Habiger DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Susan E. Morano DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Cathy R. Smith DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Christophe P. Weber DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Proposal to elect ten Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year. AUDIT-RELATED ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance. COMPENSATION ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to remove supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders. CORPORATE GOVERNANCE ISSUER 692448.000000 0 FOR 692448.000000 FOR S000005666 Boston Scientific Corporation 101137107 US1011371077 04/30/2026 Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting." CORPORATE GOVERNANCE SECURITY HOLDER 692448.000000 0 AGAINST 692448.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D. DIRECTOR ELECTIONS ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D. DIRECTOR ELECTIONS ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani DIRECTOR ELECTIONS ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To approve the amended and restated Gilead Sciences, Inc. 2022 Equity Incentive Plan. COMPENSATION ISSUER 286000.000000 0 FOR 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 286000.000000 0 AGAINST 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. OTHER SOCIAL ISSUES SECURITY HOLDER 286000.000000 0 AGAINST 286000.000000 FOR S000005666 Gilead Sciences, Inc. 375558103 US3755581036 04/30/2026 To vote on a stockholder proposal requesting a report on the risks of ESG and DEI executive compensation metrics, if properly presented at the Annual Meeting. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 286000.000000 0 AGAINST 286000.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 Election of Directors: David J. Rosa DIRECTOR ELECTIONS ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 Intuitive Surgical, Inc. 46120E602 US46120E6023 04/30/2026 To approve the amendment and restatement of the Company's Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 123020.000000 0 FOR 123020.000000 FOR S000005666 UCB SA B93562120 BE0003739530 04/30/2026 Approve Financial Statements, Allocation of Income, and Dividends of EUR 1.45 per Share CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 UCB SA B93562120 BE0003739530 04/30/2026 Approve Remuneration Report COMPENSATION ISSUER 0.000000 0 S000005666 UCB SA B93562120 BE0003739530 04/30/2026 Approve Discharge of Directors CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 UCB SA B93562120 BE0003739530 04/30/2026 Approve Discharge of Auditors AUDIT-RELATED CORPORATE GOVERNANCE ISSUER 0.000000 0 S000005666 UCB SA B93562120 BE0003739530 04/30/2026 Reelect Jean-Christophe Tellier as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 UCB SA B93562120 BE0003739530 04/30/2026 Reelect Cedric van Rijckevorsel as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 S000005666 UCB SA B93562120 BE0003739530 04/30/2026 Approve Renewal of Change-of-Control Clause Re: EMTN Program - Art. 7:151 of the BCCA SHAREHOLDER RIGHTS AND DEFENSES CAPITAL STRUCTURE ISSUER 0.000000 0 S000005666 UCB SA B93562120 BE0003739530 04/30/2026 Renew Authorization to Increase Share Capital within the Framework of Authorized Capital CAPITAL STRUCTURE ISSUER 0.000000 0 S000005666 UCB SA B93562120 BE0003739530 04/30/2026 Authorize Share Repurchase Program and Reissuance of Repurchased Shares CAPITAL STRUCTURE ISSUER 0.000000 0 S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: Carolyn Bertozzi DIRECTOR ELECTIONS ISSUER 171340.000000 0 FOR 171340.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: William Kaelin, Jr. DIRECTOR ELECTIONS ISSUER 171340.000000 0 FOR 171340.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: Jon Moeller DIRECTOR ELECTIONS ISSUER 171340.000000 0 FOR 171340.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Election of the following directors, each to serve a three-year term: David Ricks DIRECTOR ELECTIONS ISSUER 171340.000000 0 FOR 171340.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 171340.000000 0 FOR 171340.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. AUDIT-RELATED ISSUER 171340.000000 0 FOR 171340.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 171340.000000 0 FOR 171340.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 171340.000000 0 FOR 171340.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. CORPORATE GOVERNANCE SECURITY HOLDER 171340.000000 0 AGAINST 171340.000000 FOR S000005666 Eli Lilly and Company 532457108 US5324571083 05/04/2026 Shareholder proposal to prepare an annual lobbying report. OTHER SOCIAL ISSUES SECURITY HOLDER 171340.000000 0 AGAINST 171340.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Paula A. Price DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Derica W. Rice DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Vote to Approve the Company's 2026 Stock Award and Incentive Plan COMPENSATION ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 530200.000000 0 FOR 530200.000000 FOR S000005666 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director CORPORATE GOVERNANCE SECURITY HOLDER 530200.000000 0 AGAINST 530200.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Approve Remuneration Report COMPENSATION ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Adopt Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Approve Allocation of Income to the Retained Earnings of the Company CAPITAL STRUCTURE ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Approve Discharge of Executive Directors CORPORATE GOVERNANCE ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Approve Discharge of Non-Executive Directors CORPORATE GOVERNANCE ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Elect Karen Massey as Executive Director DIRECTOR ELECTIONS ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Elect Tim Van Hauwermeiren as Non-Executive Director DIRECTOR ELECTIONS ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Reelect Ana Cespedes as Non-Executive Director DIRECTOR ELECTIONS ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Reelect Camilla Sylvest as Non-Executive Director DIRECTOR ELECTIONS ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Reelect Pamela Klein as Non-Executive Director DIRECTOR ELECTIONS ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Grant Board Authority to Issue Shares Up to 10 Percent of Issued Capital and Limit/Exclude Preemptive Rights CAPITAL STRUCTURE ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 argenx SE N0610Q109 NL0010832176 05/06/2026 Ratify Ernst & Young Accountants LLP as Auditors AUDIT-RELATED ISSUER 20864.000000 0 FOR 20864.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Approve Remuneration Report COMPENSATION ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Amend Remuneration Policy COMPENSATION ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Elect Luke Miels as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Sir Jonathan Symonds as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Julie Brown as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Elizabeth Anderson as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Charles Bancroft as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Hal Barron as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Anne Beal as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Wendy Becker as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Harry Dietz as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Jeannie Lee as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Gavin Screaton as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Re-elect Vishal Sikka as Director DIRECTOR ELECTIONS ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Reappoint Deloitte LLP as Auditors AUDIT-RELATED ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Authorise the Audit & Risk Committee to Fix Remuneration of Auditors AUDIT-RELATED ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Authorise UK Political Donations and Expenditure OTHER SOCIAL ISSUES ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Authorise Issue of Equity CAPITAL STRUCTURE ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Authorise Issue of Equity without Pre-emptive Rights CAPITAL STRUCTURE ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment CAPITAL STRUCTURE ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Authorise Market Purchase of Ordinary Shares CAPITAL STRUCTURE ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Approve the Exemption from Statement of the Name of the Senior Statutory Auditor in Published Copies of the Auditors' Reports OTHER Company-specific matter ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Authorise the Company to Call General Meeting with Two Weeks' Notice CORPORATE GOVERNANCE ISSUER 509032.000000 0 AGAINST 509032.000000 AGAINST S000005666 GSK Plc G3910J179 GB00BN7SWP63 05/06/2026 Amend Articles of Association CORPORATE GOVERNANCE ISSUER 509032.000000 0 FOR 509032.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Leslie C. Davis DIRECTOR ELECTIONS ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: David T. Feinberg, MD DIRECTOR ELECTIONS ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Kieran T. Gallahue DIRECTOR ELECTIONS ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Leslie S. Heisz DIRECTOR ELECTIONS ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Paul A. LaViolette DIRECTOR ELECTIONS ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Steven R. Loranger DIRECTOR ELECTIONS ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Ramona Sequeira DIRECTOR ELECTIONS ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Nicholas J. Valeriani DIRECTOR ELECTIONS ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Election of Directors: Bernard Zovighian DIRECTOR ELECTIONS ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 Edwards Lifesciences Corporation 28176E108 US28176E1082 05/07/2026 Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program COMPENSATION ISSUER 298500.000000 0 FOR 298500.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Jennifer L. Davis DIRECTOR ELECTIONS ISSUER 406900.000000 0 FOR 406900.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Melody B. Meyer DIRECTOR ELECTIONS ISSUER 406900.000000 0 FOR 406900.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Robert A. Michael DIRECTOR ELECTIONS ISSUER 406900.000000 0 FOR 406900.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Election of Class II Directors: Frederick H. Waddell DIRECTOR ELECTIONS ISSUER 406900.000000 0 FOR 406900.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 AUDIT-RELATED ISSUER 406900.000000 0 FOR 406900.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 406900.000000 0 FOR 406900.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 406900.000000 0 FOR 406900.000000 FOR S000005666 AbbVie Inc. 00287Y109 US00287Y1091 05/08/2026 Stockholder Proposal - to Adopt a Policy to Require an Independent Chair CORPORATE GOVERNANCE SECURITY HOLDER 406900.000000 0 FOR 406900.000000 AGAINST S000005666 Insmed Incorporated 457669307 US4576693075 05/13/2026 Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Elizabeth McKee Anderson DIRECTOR ELECTIONS ISSUER 89900.000000 0 FOR 89900.000000 FOR S000005666 Insmed Incorporated 457669307 US4576693075 05/13/2026 Election of two Class II directors, Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D. to serve until the 2029 Annual Meeting of Shareholders: Clarissa Desjardins, Ph.D. DIRECTOR ELECTIONS ISSUER 89900.000000 0 FOR 89900.000000 FOR S000005666 Insmed Incorporated 457669307 US4576693075 05/13/2026 An advisory vote on the 2025 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 89900.000000 0 FOR 89900.000000 FOR S000005666 Insmed Incorporated 457669307 US4576693075 05/13/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 89900.000000 0 FOR 89900.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Sangeeta Bhatia DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Lloyd Carney DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Alan Garber DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Reshma Kewalramani DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Michel Lagarde DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Jeffrey Leiden DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Diana McKenzie DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Bruce Sachs DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Jennifer Schneider DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Election of Directors: Nancy Thornberry DIRECTOR ELECTIONS ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Approval of 2026 Stock and Option Plan. COMPENSATION ISSUER 73860.000000 0 FOR 73860.000000 FOR S000005666 Vertex Pharmaceuticals Incorporated 92532F100 US92532F1003 05/13/2026 Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. CORPORATE GOVERNANCE SECURITY HOLDER 73860.000000 0 AGAINST 73860.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Fernando Aguirre DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Jeffrey R. Balser, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: C. David Brown II DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Alecia A. DeCoudreaux DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Anne M. Finucane DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: John E. Gallina DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: J. David Joyner DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: J. Scott Kirby DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Larry M. Robbins DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Guy P. Sansone DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Election of Directors: Douglas H. Shulman DIRECTOR ELECTIONS ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. AUDIT-RELATED ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Proposal to Approve the Company's 2026 Incentive Compensation Plan. COMPENSATION ISSUER 440300.000000 0 FOR 440300.000000 FOR S000005666 CVS Health Corporation 126650100 US1266501006 05/14/2026 Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. CORPORATE GOVERNANCE SECURITY HOLDER 440300.000000 0 AGAINST 440300.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2027 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 60480.000000 0 FOR 60480.000000 FOR S000005666 Amgen Inc. 031162100 US0311621009 05/19/2026 Stockholder proposal to require an independent board chairman. CORPORATE GOVERNANCE SECURITY HOLDER 60480.000000 0 AGAINST 60480.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 133880.000000 0 AGAINST 133880.000000 AGAINST S000005666 Thermo Fisher Scientific Inc. 883556102 US8835561023 05/20/2026 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2026. AUDIT-RELATED ISSUER 133880.000000 0 FOR 133880.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Ratification of the appointment of the Company's independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 601971.000000 0 FOR 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on DEI risks in federal contracting. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 601971.000000 0 AGAINST 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on healthcare coverage gaps. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 601971.000000 0 AGAINST 601971.000000 FOR S000005666 Merck & Co., Inc. 58933Y105 US58933Y1055 05/26/2026 Shareholder proposal regarding a report on political contributions. OTHER SOCIAL ISSUES SECURITY HOLDER 601971.000000 0 AGAINST 601971.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Charles Baker DIRECTOR ELECTIONS ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Timothy Flynn DIRECTOR ELECTIONS ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Paul Garcia DIRECTOR ELECTIONS ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Kristen Gil DIRECTOR ELECTIONS ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: F. William McNabb III DIRECTOR ELECTIONS ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Election of Directors: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2026. AUDIT-RELATED ISSUER 266960.000000 0 FOR 266960.000000 FOR S000005666 UnitedHealth Group Incorporated 91324P102 US91324P1021 06/01/2026 If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. CORPORATE GOVERNANCE SECURITY HOLDER 266960.000000 0 AGAINST 266960.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Dawn Svoronos DIRECTOR ELECTIONS ISSUER 134200.000000 0 AGAINST 134200.000000 AGAINST S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gillian Cannon DIRECTOR ELECTIONS ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Steven Gannon DIRECTOR ELECTIONS ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Elizabeth Garofalo DIRECTOR ELECTIONS ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Justin Gover DIRECTOR ELECTIONS ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Patrick Machado DIRECTOR ELECTIONS ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Ian Mortimer DIRECTOR ELECTIONS ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gary Patou DIRECTOR ELECTIONS ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To approve, on an advisory basis, the compensation of the Corporation's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 134200.000000 0 ONE YEAR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To approve the Corporation's 2026 Equity Incentive Plan; COMPENSATION ISSUER 134200.000000 0 AGAINST 134200.000000 AGAINST S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To appoint PricewaterhouseCoopers LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation; AUDIT-RELATED ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Xenon Pharmaceuticals Inc. 98420N105 CA98420N1050 06/02/2026 To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation; and AUDIT-RELATED ISSUER 134200.000000 0 FOR 134200.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Joseph L. Goldstein, M.D. DIRECTOR ELECTIONS ISSUER 19578.000000 0 FOR 19578.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Christine A. Poon DIRECTOR ELECTIONS ISSUER 19578.000000 0 FOR 19578.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: David P. Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 19578.000000 0 FOR 19578.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Craig B. Thompson, M.D. DIRECTOR ELECTIONS ISSUER 19578.000000 0 FOR 19578.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Election of Directors: Huda Y. Zoghbi, M.D. DIRECTOR ELECTIONS ISSUER 19578.000000 0 FOR 19578.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 19578.000000 0 FOR 19578.000000 FOR S000005666 Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/12/2026 Proposal to approve, on an advisory basis, compensation of the Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 19578.000000 0 FOR 19578.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Randal Kirk DIRECTOR ELECTIONS ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Cesar Alvarez DIRECTOR ELECTIONS ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Steven Frank DIRECTOR ELECTIONS ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Vinita Gupta DIRECTOR ELECTIONS ISSUER 910700.000000 0 AGAINST 910700.000000 AGAINST S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Fred Hassan DIRECTOR ELECTIONS ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Jeffrey Kindler DIRECTOR ELECTIONS ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Nancy Howell Agee DIRECTOR ELECTIONS ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: Helen Sabzevari DIRECTOR ELECTIONS ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Election of Directors: James Turley DIRECTOR ELECTIONS ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 910700.000000 0 FOR 910700.000000 FOR S000005666 Precigen, Inc. 74017N105 US74017N1054 06/18/2026 Company Proposal - Approval of an amendment to the 2023 Omnibus Incentive Plan. COMPENSATION ISSUER 910700.000000 0 AGAINST 910700.000000 AGAINST S000005666 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis Borisy DIRECTOR ELECTIONS ISSUER 65300.000000 0 FOR 65300.000000 FOR S000005666 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Mark A. Goldsmith, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 65300.000000 0 FOR 65300.000000 FOR S000005666 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026; and AUDIT-RELATED ISSUER 65300.000000 0 FOR 65300.000000 FOR S000005666 Revolution Medicines, Inc. 76155X100 US76155X1000 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 65300.000000 0 FOR 65300.000000 FOR S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David W.J. McGirr DIRECTOR ELECTIONS ISSUER 120200.000000 0 WITHHOLD 120200.000000 AGAINST S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 Election of the Class III directors, each to serve for a three year term until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: David P. Meeker, M.D. DIRECTOR ELECTIONS ISSUER 120200.000000 0 WITHHOLD 120200.000000 AGAINST S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 120200.000000 0 FOR 120200.000000 FOR S000005666 Rhythm Pharmaceuticals, Inc. 76243J105 US76243J1051 06/24/2026 Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 120200.000000 0 AGAINST 120200.000000 AGAINST S000005666 HOYA Corp. J22848105 JP3837800006 06/26/2026 Elect Director Yoshihara, Hiroaki DIRECTOR ELECTIONS ISSUER 109700.000000 0 FOR 109700.000000 FOR S000005666 HOYA Corp. J22848105 JP3837800006 06/26/2026 Elect Director Abe, Yasuyuki DIRECTOR ELECTIONS ISSUER 109700.000000 0 FOR 109700.000000 FOR S000005666 HOYA Corp. J22848105 JP3837800006 06/26/2026 Elect Director Hasegawa, Takayo DIRECTOR ELECTIONS ISSUER 109700.000000 0 FOR 109700.000000 FOR S000005666 HOYA Corp. J22848105 JP3837800006 06/26/2026 Elect Director Nishimura, Mika DIRECTOR ELECTIONS ISSUER 109700.000000 0 FOR 109700.000000 FOR S000005666 HOYA Corp. J22848105 JP3837800006 06/26/2026 Elect Director Sato, Mototsugu DIRECTOR ELECTIONS ISSUER 109700.000000 0 FOR 109700.000000 FOR S000005666 HOYA Corp. J22848105 JP3837800006 06/26/2026 Elect Director Ikeda, Eiichiro DIRECTOR ELECTIONS ISSUER 109700.000000 0 FOR 109700.000000 FOR S000005666 HOYA Corp. J22848105 JP3837800006 06/26/2026 Elect Director Hiroka, Ryo DIRECTOR ELECTIONS ISSUER 109700.000000 0 FOR 109700.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Christopher Causey DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Richard Giltner DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Ray Kurzweil DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Jan Malcolm DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Linda Maxwell DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Nilda Mesa DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Judy Olian DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Christopher Patusky DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Martine Rothblatt DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Louis Sullivan DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Tommy Thompson DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Election of Directors: Kevin Tracey DIRECTOR ELECTIONS ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Advisory resolution to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. COMPENSATION ISSUER 15840.000000 0 AGAINST 15840.000000 AGAINST S000005666 United Therapeutics Corporation 91307C102 US91307C1027 06/26/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026. AUDIT-RELATED ISSUER 15840.000000 0 FOR 15840.000000 FOR S000005666